Skip to content
Acting Auditions – Lifestyle
Author:
NEKTAR THERAPEUTICS
Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
March 20, 2026
←
Previous Page
1
2
3